Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study-Reference-Cited by-同舟云学术

Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study

Published:2023-11-10 Issue:20 Volume:149 Page:17881-17896
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Guo Jianping,Deng Zijian,Jin Longyang,Yin Shi,Xiong Zhizhong,Wang Caiqin,Chen Huaxian,Luo Dandong,Huang Dayin,Peng Junsheng,Chen Shi,Lian Lei

Funder

National Natural Science Foundation of China

Guangdong Natural Science Fund for Outstanding Youth Scholars

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05481-9.pdf

Reference34 articles.

1. Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C et al (2022) Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20(2):167–192. https://doi.org/10.6004/jnccn.2022.0008

2. Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B et al (2019) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol 37(23):2028–2040. https://doi.org/10.1200/jco.18.01688

3. Bonnot PE, Lintis A, Mercier F, Benzerdjeb N, Passot G, Pocard M et al (2021) Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study). Br J Surg 108(10):1225–1235. https://doi.org/10.1093/bjs/znab200

4. Casado-Adam A, Alderman R, Stuart OA, Chang D, Sugarbaker PH (2011) Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Int J Surg Oncol 2011:468698. https://doi.org/10.1155/2011/468698

5. Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y et al (2017) The 30-year experience—a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer 79:1–14. https://doi.org/10.1016/j.ejca.2017.03.030

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching;World Journal of Surgical Oncology;2024-09-11

2. Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching;2024-06-12